BIO SAFETY

Safety Form

The safety form can be found here.

Safety in Microfluidics

When handling Genetically Modified Organisms biosafety is a primordial factor to take into consideration. Mishandling Genetically Modified Organisms can be dangerous. With this in mind, the 2014 EPFL iGEM team strived to find novel ways to address biosafety in the rapidly evolving world of synthetic biology.

The use of microfluidics throughout our project sparked an idea within our team: microfluidics could be used as a powerful tool to improve biosafety when handling Genetically Modified Organisms. Microfluidics provides an enclosed space to culture and analyse engineered organisms, thus reducing the risk of releasing them in the environment.

To develop this idea, we brainstormed on how we could provide a safe and practical microfluidic context for synthetic biological systems. We imagined a few improvements to current existing devices and discussed them with 2 professors teaching at EPFL and the university of Lausanne, experts in the interface between biology and microfluidics:

- Pr.John McKinney, who is the head of the Laboratory of Microbiology and Microsystems at EPFL (Ecole Polytechnique Fédérale de Lausanne) and uses microfluidics to study pathogenic strains such as uropathogenic E. coli or M.tuberculosis

- Pr.Jan van der Meer, who is the head of the Department of Fundamental Microbiology at UNIL (Université de Lausanne) and works on implementing biosensors in a microfluidic chip

Discover here what came out of these interviews and how we took advantage of microfluidics to design a completely safe device!

What are the safety issues related to synthetic biology?

The commercialization of devices containing GMOs – just like our BioPad – must address biosafety related concerns that currently don’t always have solutions.

When brainstorming about biosafety issues related to GMOs, we realized that one of the main dangers is the release of genetically modified organisms in the environment. Horizontal gene transfer could lead to the spread of new competences to other organisms. This is especially true for plasmids containing antibiotic resistance genes. Their release could favour the development of new antibiotic resistant strains – an omnipresent threat to modern medicine.

A second possible issue could arise when handling pathogenic strains or strains that can become pathogenic upon transformation. In this case, it is vital that the devices containing the organisms do not pose any threats to human health. Thankfully, synthetic biological systems based on pathogens are quite seldom made. We nevertheless think that it could be helpful to design devices limiting the risks of contamination.

What are the main advantages of microfluidics regarding biosafety?

The most significant advantage of using microfluidics is that it constitutes a closed environment: cells are hermetically trapped between the glass slide and the PDMS chip. This minimizes the manipulation of open liquid cultures, which reduces the risks of contamination and release of dangerous biological components in the environment. One could still argue that cells can leave the chip if liquid is actively flowed through it (for example to continuously provide cells with fresh medium). In John McKinney’s lab, they solved this problem by connecting the outlet of the chip to a bottle containing bleach or ethanol; this allows immediate decontamination of any liquid leaving the chip.

The second advantage of microfluidics is size reduction. Only minute amounts of cells or media need to be manipulated. In comparison to analyses on 96-well plates, where typical reaction volumes are about 100 µL (approximately 107 cells for an overnight bacterial culture), microfluidics allows the manipulation of nanoliter-range volumes, corresponding to only 103-104 cells. This is of critical importance when handling pathogens as it limits the risk of contamination by drastically decreasing the exposure dose.

Size reduction is also crucial to commercialize biosensor devices containing GMOs. As Jan van der Meer explained to us, the current regulations concerning biosensor devices depends not only on the type of organism used but also on the amount of cells that the device contains. Designing biosensors based on microfluidics could therefore make acceptance of GMO containing devices easier by the regulation authorities. For more information on regulation of biosensors in Switzerland, we encourage you to visit this website.

Are there any other drawbacks?

Since microfluidics is a very recent tool regarding biological studies, there are still some points that need to be optimized as far as biosafety is concerned.

First of all, the chip remains a hermetically closed space as long as the bonding between the glass slide and the PDMS is perfect. It sometimes happens that the chip delaminates, i.e. that the PDMS unsticks from the glass. This is often the case when liquids are flowed into the chip with a very high pressure or when cells form clots that block the channels, leading to local increase in pressure. Delamination is a real safety problem as it leads to release of cells in the environment and thus possible contamination. Yet it can be avoided by plasma-treating both glass slide and PDMS, which makes the bonding permanent. Another solution that is used in McKinney’s lab is to clamp the PDMS and the glass slide together but this is generally not-suited for long-term applications or when the chip is intended to be commercialized as a biosensor.

A second issue is that the assembly and disassembly of the chip still needs to be done under a biosafety cabinet as it involves manipulation of open liquid. There are usually 2 options to load a chip with cells:

• either one can bond the glass and the PDMS and then flow cells through inlets that are punched in the PDMS, which is the option we chose in our project.

• or the cells can be spotted on the glass slide and then bond the PDMS on top of them. This solution requires smaller amounts of cells but is not compatible with plasma-treatment as the PDMS chip has to be aligned very precisely to the cells whereas plasma-bonding is a one-shot process.

Depending on the kind of cells/media/pressures that are used, one therefore has to find a compromise between manipulating open liquids and reducing the risk of delamination.

John McKinney also pointed out 2 other shortcomings that could be problematic in some specific cases. First of all, microfluidics are not very well adapted for long-term experiments (for example studies of slowly growing strains), since PDMS is known to lose its mechanical properties with time, which could increase the risk of delamination. Second, bleach or ethanol are inefficient to decontaminate spores, which could make it difficult to run microfluidic experiments with sporulating strains such as anthrax, as they could leave the chip without being killed.

What possible improvements did the professors do?

To tackle the problems mentioned above, one can think of several solutions. The professors presented some dispositions they took in their lab, then we also brainstormed on our side on how biosafety could be improved.

John McKinney first explained to us what they are doing in his lab to prevent any cell from leaving the chip, even through the outlet tubing. They actually add a dialysis membrane between the cells and the PDMS chip, so that cells are trapped between the glass slide and the membrane. The latter consists of nanometer-range pores, which prevents cells and even large proteins from leaving the chip. This is interesting when handling sporulating species or toxin-producing strains as it would avoid any contamination by spores or harmful toxins.

To tackle this issue of keeping every cells on the chip, we thought of adding 0.2 µm filters at the end of the array of chambers, so that only medium can flow out of the chip. This also seemed to be a proper solution to deal with sporulating species. But it then appears that cells could form clots just before the filters, thus blocking the liquid and finally leading to delamination. An interesting solution to this problem was engineered in van der Meer’s lab: instead of directly flowing cells through the chip, these are embedded in agarose beads which size is much larger than the size of the filters. Therefore, cells are trapped in agarose and can neither clot the filters nor leave the chip. Another advantage of this technique is that the chip can be pre-filled with beads and then stored at -20°C before running the experiment, which is of great interest if one thinks of engineering a completely portable device. The only issue when handling cells in biomaterials is to be able to control the feed the cells. Indeed, bioreporter cells need a continuous energy input to be able to produce the desired reporter proteins. When cells are trapped in a biomaterial, the reaction time can become extremely long as the diffusion of medium through the gel is hampered. Once again, one has to find a compromise between safety and efficiency.

What possible improvements did we imagine?

After doing these interviews and some thought processing, we thought of potential implementations in microfluidics to increase safety:
• Do a continuous lysis buffer, ethanol or bleach flow that will mix with the cells that should leave the outlet.
• add a suction device on the chip to assure the bonding between the chip and the glass slide, for experiments that need to do spotting.
• add a microheater to kill any cells that would leave the chip to kill cells and potentially spores.

With this in mind, we came up with a with a new chip design. This chip, CleanColi, is actually an extension of any kind of chip and is intended to be put before the outlet. It includes several decontamination steps to provide total on-chip waste treatment, thus avoiding any leakage of potential harmful organisms in the environment. You can find more about it here.